Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407378
Max Phase: Preclinical
Molecular Formula: C33H39N3O7
Molecular Weight: 589.69
Molecule Type: Protein
Associated Items:
ID: ALA2407378
Max Phase: Preclinical
Molecular Formula: C33H39N3O7
Molecular Weight: 589.69
Molecule Type: Protein
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)[C@@H](O)c1ccccc1
Standard InChI: InChI=1S/C33H39N3O7/c1-22(2)19-26(35-33(41)43-21-24-15-9-5-10-16-24)30(38)36-28(29(37)25-17-11-6-12-18-25)31(39)34-27(32(40)42-3)20-23-13-7-4-8-14-23/h4-18,22,26-29,37H,19-21H2,1-3H3,(H,34,39)(H,35,41)(H,36,38)/t26-,27-,28+,29-/m0/s1
Standard InChI Key: CJPYWUBTBSVCNB-FKWFRFQNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 589.69 | Molecular Weight (Monoisotopic): 589.2788 | AlogP: 3.45 | #Rotatable Bonds: 14 |
Polar Surface Area: 143.06 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.78 | CX Basic pKa: | CX LogP: 4.30 | CX LogD: 4.30 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.21 | Np Likeness Score: 0.11 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):